Published online May 1, 2008
PEDIATRICS Vol. 121 No. 5 May 2008, pp. 1002-1009 (doi:10.1542/peds.2007-2008)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Rani, F.
Right arrow Articles by Wong, I. C. K.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rani, F.
Right arrow Articles by Wong, I. C. K.
Related Collections
Right arrow Therapeutics & Toxicology

ARTICLE

Epidemiologic Features of Antipsychotic Prescribing to Children and Adolescents in Primary Care in the United Kingdom

Fariz Rani, BPharma,b, Macey L. Murray, BSca,b,c, Patrick J. Byrne, FRCPsychd,e and Ian C. K. Wong, PhDa,b

a Centre for Paediatric Pharmacy Research, School of Pharmacy, University of London, London, England
b Institute of Child Health, University College London, London, England
c Task-force of European Drug Development for the Young (TEDDY)
d Department of Adolescent Psychiatry, Bethlem Royal Hospital, South London, England
e Maudsley National Health Service Trust, Beckenham, England

OBJECTIVE. The goal was to investigate the epidemiologic features of antipsychotic prescribing to children and adolescents in general practice in the United Kingdom.

METHODS. A total of 384 participating general practices from the United Kingdom General Practice Research Database were used to identify patients 0 to 18 years of age who were prescribed ≥1 antipsychotic medication between January 1, 1992, and December 31, 2005. Annual age-specific prevalences and incidences of antipsychotic prescribing were calculated.

RESULTS. The overall prevalence of use of all antipsychotics increased from 1992 (0.39 users per 1000 patient-years) to 2005 (0.77 users per 1000 patient-years). The prescribing prevalence for patients 7 to 12 years of age almost tripled between 1992 (0.23 users per 1000 patient-years) and 2005 (0.61 users per 1000 patient-years). Atypical antipsychotic prescribing increased 60-fold from 1994 (0.01 users per 1000 patient-years) to 2005 (0.61 users per 1000 patient-years). However, typical antipsychotic prescribing decreased significantly from 2000 (0.44 users per 1000 patient-years) to 2005 (0.18 users per 1000 patient-years). The incidences for typical and atypical antipsychotics showed trends similar to those of the respective prevalences. However, the overall incidence (number of new starters) for all antipsychotics was relatively stable between 1992 and 2005, which suggests that patients remain on treatment longer.

CONCLUSIONS. The overall prevalence of antipsychotics almost doubled between 1992 and 2005; however, the rate of increase was much lower than the reported figures in the United States. The prescribing of atypical antipsychotic drugs has increased despite the lack of conclusive evidence showing their superiority over older conventional antipsychotics. Additional investigation is required to evaluate their efficacy and safety in children and adolescents.

Key Words: drug utilization • pharmacoepidemiology • pediatric • antipsychotics

Abbreviations: GPRD—General Practice Research Database • CI—confidence interval

Accepted Sep 17, 2007.




This article has been cited by other articles:


Home page
 JWatch PsychiatryHome page
Antipsychotic Prescribing Trends in U.K. Children
Journal Watch Psychiatry, June 23, 2008; 2008(623): 5 - 5.
[Full Text]